Helen of Troy’s margin recovery looks partly real, but not all of it is underlying. The quarter was clearly better than the very weak fiscal Q2 2026 comparison, with revenue up to $440.9 million in FY2027 Q2 from $431.8 million in FY2026 Q2 and net income back to a positive $4.6 million from a loss of $308.6 million, according to the reported financial statements. However, the sharp improvement in gross margin was helped materially by tariff refunds, and adjusted profitability was still held back by a heavier SG&A load and litigation-related costs that management now excludes from non-GAAP measures. In short: the recovery is visible at the gross profit line, but the cleaner measure of operating improvement is more modest than the headline suggests. 243120
Q2 FY2027 | Q2 FY2026 | Change | |
|---|---|---|---|
Revenue | 440.9 | 431.8 | 2.1% |
Net income | 4.6 | -308.6 | n/m |
Quarter ended August 31, 2026 vs quarter ended August 31, 2025. Relative change is not shown for net income because the comparison base was negative.
Gross margin improvement was substantial, but tariff refunds were a major driver
The clearest sign of recovery in fiscal Q2 2027 was gross margin. Management said consolidated gross profit margin increased 8.0 percentage points to 52.2% from 44.2% in fiscal Q2 2026. The company explicitly attributed this primarily to “the favorable impact of tariff refunds, net of higher tariff costs, and lower overall retail trade and promotional expense year-over-year.” 31
That matters for quality of earnings. A gross margin gain driven by mix improvement, pricing power, or sustainably lower input costs would usually point to a more repeatable recovery. Here, management itself points first to tariff refunds, which are beneficial but not a clean read-through to normalized profitability. The same MD&A also notes offsets from inflationary product cost pressure linked to commodities, fuel prices, freight, foreign currency and supply availability, as well as a less favorable inventory obsolescence impact year-over-year. 31
The comparison base was also unusually weak. In fiscal Q2 2026, gross profit margin had fallen 1.4 percentage points to 44.2%, primarily due to higher tariffs and higher retail trade and promotional expense, partly offset by lower commodity and product costs and a favorable contribution from Olive & June. That means part of the current-year rebound is simply a reversal of prior-year pressure rather than evidence that the business has fully reset structurally. 133
Revenue growth was positive, but the sales mix still looks mixed rather than broad-based
Top-line development was positive but not especially strong. Fiscal Q2 2027 revenue rose 2.1% year-on-year to $440.9 million, while first-half FY2027 revenue reached $843.0 million, up 4.9% from $803.4 million in the prior-year period, according to the reported financial statements and the company’s MD&A. 24
Within Beauty & Wellness, management highlighted growth in nail care from strong consumer demand and new and expanded distribution, as well as incremental sales from new product launches. Offsetting that, Beauty hair appliances and prestige hair care declined due to softer demand, consumer price sensitivity, ongoing competition, reduced replenishment orders from retailers and lower closeout sales. 31
That commentary suggests the revenue recovery is not yet fully broad-based. There are clear pockets of strength, but the company is still battling weak discretionary demand and retailer caution in parts of the portfolio. The online channel did improve: online channel net sales represented about 25% of consolidated net sales in the three months ended August 31, 2026 and grew about 4% year-on-year, versus a 22% decline in the comparable prior-year quarter. That is a useful stabilization signal, but still not enough on its own to prove a fully restored growth engine. 15
Below gross profit, the picture is less convincing
The biggest reason to be cautious on the margin recovery is that the benefit at gross margin did not flow through cleanly to operating profitability. Management said the consolidated SG&A ratio increased 5.4 percentage points to 46.4% from 41.0% in fiscal Q2 2026. 31
So while gross margin improved by 8.0 percentage points, a large part of that was absorbed further down the P&L. This makes the recovery real in one sense — product profitability improved — but less complete in another sense, because the cost structure still consumed much of the benefit. The company’s first-half figures do show progress at the broader level, with gross profit of $415.0 million in FY2027 H1 versus $365.7 million in FY2026 H1, and SG&A down to $329.2 million from $344.7 million, producing operating income of $83.3 million versus a loss of $722.8 million in the prior-year period. But that first-half comparison is heavily distorted by the prior year’s $740.8 million asset impairment charges. 2424
The prior-year distortions are significant. In fiscal Q2 2026, the company recognized $326.4 million of non-cash asset impairment charges, largely tied to goodwill and intangible assets across multiple brands and driven primarily by the sustained decline in the company’s stock price. That pushed the reported operating margin to negative 73.1% in fiscal Q2 2026, versus 7.3% in fiscal Q2 2025. 1
As a result, any reported GAAP comparison into fiscal Q2 2027 will overstate the degree of underlying recovery. The impairment reset makes this year’s return to positive earnings look dramatic, but it is not the best indicator of core operating momentum. 146
Non-GAAP treatment helps assess the trend, but it also requires care
Management’s non-GAAP framework is useful here because it strips out the prior-year impairment charges and some current-year non-operating items. The company explains that adjusted operating income, adjusted operating margin, adjusted income and adjusted diluted EPS exclude items such as asset impairment charges, CEO succession costs, the gain on sale of a distribution facility, divestiture litigation costs, restructuring charges, amortization of intangible assets and non-cash share-based compensation, as applicable. 1246
One important development in fiscal Q2 2027 is that, beginning with the second quarter, management decided to exclude divestiture litigation costs from non-GAAP measures going forward. For the three and six months ended August 31, 2026, adjusted operating income and adjusted income exclude $4.0 million of divestiture litigation costs. Management justified this by saying these costs relate to a divestiture completed more than five years ago and are not normal operating expenses tied to ongoing operations or business strategy. 20
That adjustment may be reasonable, but it does mean investors should separate two questions:
Is the core operating business improving? Probably yes, especially at gross margin.
Is all of the reported or adjusted recovery purely recurring and clean? Not yet.
The presence of tariff refunds and a newly excluded litigation cost means the quarter’s recovery should not be treated as fully normalized earnings power.
Segment and strategic context suggest early progress, not a finished turnaround
The broader strategic commentary remains consistent with a business still in the early stages of repair. In fiscal Q1 2027, management described the company as making “early signs of progress” against its multi-year roadmap, citing POS gains in several key brands while also saying “there is still meaningful work ahead” and that it was navigating a dynamic operating environment. 1
That framing still fits Q2. The company is benefiting from some genuine operating improvements, but not from a fully stabilized demand environment. Inflation, evolving tariff policies, competition and changes in consumer spending patterns remain explicit risk factors in management’s discussion. 15
Balance-sheet and liquidity indicators are stable rather than stressed. Cash and cash equivalents were $22.6 million at FY2027 Q2, up from $21.7 million at FY2027 Q1, and current assets were $876.3 million against current liabilities of $531.0 million at August 31, 2026, according to the reported financial statements. Long-term debt had already been reduced to $785.5 million at FY2026 year-end from $921.9 million at FY2025 year-end. This supports the view that Helen of Troy has room to execute the turnaround, even if profitability remains uneven.
Bottom line: some of the recovery is real, but the headline overstates the underlying improvement
My read is that the margin recovery in fiscal Q2 2027 is real at the gross profit level, but only partly structural. The business did improve versus a difficult prior-year quarter, and there are signs of better execution, healthier select categories and less pressure from trade spending. 3115
However, the quality of the improvement is mixed:
gross margin was helped materially by tariff refunds rather than only by enduring business gains; 31
SG&A deleveraging limited the drop-through of gross profit into operating earnings; 31
year-on-year GAAP comparisons are flattered by the absence of prior-year impairment charges; 124
and the quarter also benefited from a non-GAAP exclusion for $4.0 million of divestiture litigation costs. 20
So if the question is “how much of the margin recovery is real?”, the answer is: enough to say the business is improving, but not enough to conclude that Helen of Troy has already reached a clean, fully repeatable margin base. The underlying trend looks better, though still fragile and supported by some non-recurring tailwinds.
Sources
Helen of Troy Limited · Part I Item 2 - MD&A · 2026
Helen of Troy Limited · Helen of Troy Limited Reports Second Quarter Fiscal 2026 Results · 2025 · p. 1
Helen of Troy Limited · Part I Item 2 - MD&A · 2025
Helen of Troy Limited · FORM 8-K · 2026 · p. 1